Replies to post #154308 on Biotech Values

[glass_half_full]

Interesting -- $27M top line for all of 2013 would need only 235 full-year patients at $115k/year.

And we know that there are more than that who are going to transition from compassionate use, no?

[masterlongevity]

Iclusig

this is absolutely the worst brand name for a drug that i have ever heard